Published in Pediatrics on December 01, 1985
Retinopathy following measles, mumps, and rubella vaccination in an immuno-incompetent girl. Int Ophthalmol (1998) 0.91
[Adverse ocular effects of vaccinations]. Ophthalmologe (2016) 0.77
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med (2000) 8.46
Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr (2000) 4.08
Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest (1991) 3.71
Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol (1969) 3.49
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med (1989) 3.32
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis (1992) 3.07
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun (1982) 2.61
Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. JAMA (1990) 2.54
A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis (1994) 2.52
Neurological complications of immunization. Ann Neurol (1982) 2.25
Canine kidney cell line for isolation of respiratory viruses. J Clin Microbiol (1979) 2.25
Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis (1990) 2.18
Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis (1997) 2.12
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09
Comparison of competitive and indirect enzyme-linked immunosorbent assays for detection of bluetongue virus antibodies in serum and whole blood. J Clin Microbiol (1987) 2.07
Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve (1981) 2.06
Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve (1983) 1.99
Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol (1980) 1.97
Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis (1986) 1.97
Temperature-sensitive mutants of respiratory syncytial virus. J Virol (1969) 1.94
Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol (1985) 1.92
Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J (2001) 1.90
Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J Immunol (1969) 1.90
Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology (1989) 1.90
Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol (1985) 1.88
Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis (1997) 1.86
The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr (2000) 1.85
Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch Neurol (1991) 1.78
Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis (1994) 1.78
Adenovirus infections in young children. Pediatrics (1985) 1.76
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months) Neurology (1993) 1.75
A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis (1995) 1.68
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis (1993) 1.67
The natural history of acute confusional migraine. Arch Neurol (1978) 1.66
Cytomegalovirus pneumonia in two infants recently adopted from China. Clin Infect Dis (1999) 1.65
The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J (1999) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Effect of rapid viral diagnosis on the management of children hospitalized with lower respiratory tract infection. Pediatr Infect Dis J (1997) 1.63
Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis (1982) 1.61
Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect Immun (1982) 1.61
Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children. J Clin Microbiol (1985) 1.59
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics (1997) 1.51
Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. J Infect Dis (1970) 1.51
Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis (1980) 1.47
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis (1998) 1.47
Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). J Pediatr (1975) 1.45
Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr (1987) 1.44
Risk of seizures after measles-mumps-rubella immunization. Pediatrics (1991) 1.43
Candidate AIDS vaccines. N Engl J Med (1995) 1.41
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis (1983) 1.41
Effect of urine latex agglutination tests on the treatment of children at risk for invasive bacterial infection. Pediatrics (1995) 1.40
Vaccine-induced hypersensitivity: reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine. J Pediatr (1969) 1.40
Neurogenic atrophy simulating facioscapulohumeral dystrophy. A dominant form. Arch Neurol (1967) 1.39
Reinfection of mice with respiratory syncytial virus. J Med Virol (1991) 1.39
Diphtheria outbreaks in immunized populations. N Engl J Med (1988) 1.38
Respiration in High Flying: (United Services Section). Proc R Soc Med (1937) 1.38
Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine (1999) 1.37
Genetic studies of respiratory syncytial virus temperature-sensitive mutants. Arch Gesamte Virusforsch (1973) 1.36
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis (1995) 1.36
Normal median nerve proximal latency in carpal tunnel syndrome: a clue to coexisting Martin-Gruber anastomosis. J Neurol Neurosurg Psychiatry (1976) 1.34
Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med (1977) 1.32
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J Pediatr (1976) 1.31
Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids. J Virol (1996) 1.29
Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis (1977) 1.26
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis (1992) 1.25
The treatment of prolonged seizure activity with intravenous diazepam. J Pediatr (1968) 1.22
Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J Clin Microbiol (1986) 1.22
Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita. Hum Mol Genet (1994) 1.22
Intracranial hemorrhage in the term newborn. Arch Neurol (1984) 1.22
Respiratory syncytial virus infection in anti-mu-treated mice. J Virol (1991) 1.20
Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Infect Immun (1980) 1.19
Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis (1996) 1.19
Poliovirus antibody response in patients with acute leukemia. J Pediatr (1971) 1.16
Electron microscopic studies of respiratory syncytial temperature-sensitive mutants. Arch Gesamte Virusforsch (1973) 1.16
Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev Infect Dis (1981) 1.15
Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun (1983) 1.14
Age-related response to two Haemophilus influenzae type b vaccines. J Pediatr (1982) 1.14
Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone. Arch Neurol (1987) 1.14
Immune correlates of protection against influenza in the human challenge model. Dev Biol (Basel) (2003) 1.13